News

Weight loss drugs may cut cancer risk by 50% according to ‘transformational’ new study
New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more effective than getting weight loss surgery.
New study shows GLP-1 weight loss drugs can significantly reduce alcohol intake
Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol use disorder.
New research on using weight loss drugs for treating alcohol use disorder
Some weight loss and diabetes drugs that use GLP-1s have been found to help people stop drinking. Channel 5's GM released a statement saying the station and its parent company require employees "to adhere to the highest ethical standards.
How much less Irish people drank while taking weight loss drugs like Ozempic: study
People booze a lot less when taking GLP-1 drugs like Ozempic, a new study out of Ireland ... statistics show. Monkey Business – stock.adobe.com Harmful alcohol use accounts for about 2.6 million ...
Weight-loss meds may give people more control over drinking, study shows
Scientists have been studying other possible health benefits of GLP-1s. Popular obesity and diabetes drugs called GLP-1 ... use disorder," Dr. Maurice O'Farrell, lead author of the study and ...
Weight loss jabs could be prescribed to treat depression, major study finds
People with mental health problems could be prioritised for weight loss jabs, experts have suggested, after a study showed they benefit both the mind and body. Analysis of data from 36 previous studies found GLP-1 medications,
Weight loss drugs unexpectedly help people drink less alcohol
GLP-1 analogues, typically prescribed for weight loss, led to a 68% reduction in alcohol intake among regular drinkers.
The Same Drugs that Assist in Weight Loss Show Signs of Reducing Alcohol Cravings
In the early days of the semaglutide weight loss wave, many of its users reported less interest in alcohol. A study now says that these effects extend well beyond the anecdotal, with individuals in an Irish study reducing alcohol by nearly two-thirds in four months,
Weight loss drugs could 'revolutionise' treatment for alcohol abuse
Weight loss drugs could "revolutionise the treatment of alcohol use disorder" by "effortlessly" slashing the amount that people drink, a study suggests. Patients prescribed them to lose weight also cut their booze intake by almost two thirds after four months,
pharmaphorum7d
Older GLP-1 drug shows glimmer of benefit in Alzheimer's
The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people with early-stage Alzheimer's has shown that the drug was able to reduce shrinking in the areas ...
News Medical on MSN3h
GLP-1 drugs linked to significant BMI reduction in children with severe obesity
Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs form part of their treatment, new research being presented at ...
Endocrinology Advisor1d
Patients With Diabetes Using GLP-1 RAs at Increased Risk for Adverse Pancreatic Outcomes
Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.
Arizona Daily Star13h
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds over 72 weeks, ...
Mass. residents who take GLP-1 drugs for obesity tend to be white and affluent. But who needs them most?
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...
Gizmodo4d
People on Ozempic Are Drinking Way Less
Ozempic and similar drugs aren’t just for weight loss, more and more research is finding. New data is the latest to show that GLP-1 medications ... for alcohol use disorder, the study ...
Morningstar5d
Mayo Clinic Study Uses Phenomix AI Algorithm to Predict GLP-1 Side Effects, Advancing Personalized Obesity Care and Drug Development
Study presented at DDW ... trial design to support drug development. The study titled, "A Genetic Risk Score Associated with Nausea Resulting from GLP-1 Agonist Treatment: A Post-Hoc Analysis ...
24/7 Wall St5d
Hims & Hers Shows It's More Than Just GLP-1 Drugs
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after revenue more than doubled, and it raised full-year guidance. Revenue hit $ ...